文献速递创伤与烧伤重症综合管理与镇静镇痛

肝损伤控制性开腹术后辅助肝动脉栓塞的应用

Adjunctive use of hepatic angioembolization following hemorrhage control laparotomy.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论回顾性队列提示,肝损伤行控制性开腹术后辅助肝动脉栓塞可能与24小时死亡率改善相关,但院内死亡率获益仅见于无严重颅脑损伤者,指征仍需前瞻性研究确定。

本研究为回顾性队列研究,利用美国外科医师学会创伤质量改进项目数据库2013年1月至2014年12月数据,评估肝损伤行控制性开腹术(HCL)后辅助肝动脉栓塞(HAE)对生存的影响。共1675例符合纳入标准,其中75例(4.5%)在HCL后接受HAE(入院至HAE中位时间5小时)。在225例倾向性评分匹配(2:1)患者中,HCL后HAE与24小时死亡率改善显著相关,但与院内死亡率无关;在无严重创伤性脑损伤(头部简明损伤定级≤3)亚组(n=189)中,辅助HAE与24小时及院内死亡率均显著改善相关。作者认为辅助HAE可能改善因肝损伤行HCL患者的生存,仍需前瞻性研究确定术后HAE的指征。

要点

  • 肝损伤行控制性开腹术后接受辅助肝动脉栓塞者仅占4.5%(75/1675),入院至栓塞中位时间5小时。
  • 225例倾向性评分匹配(2:1)分析中,HCL后HAE与24小时死亡率改善显著相关,但与院内死亡率无关。
  • 无严重创伤性脑损伤(头部简明损伤定级≤3)亚组(n=189)中,辅助HAE与24小时及院内死亡率均显著改善相关。
  • 作者认为辅助HAE可能改善因肝损伤行HCL患者的生存,术后HAE指征仍需前瞻性研究确定。

适用人群与场景

  • 因肝损伤需要行控制性开腹术(HCL)的创伤患者,数据来自美国外科医师学会创伤质量改进项目数据库2013年1月至2014年12月。
  • 亚组分析人群为无严重创伤性脑损伤者(头部简明损伤定级≤3,n=189)。

处置流程与药物剂量

  • 肝损伤行控制性开腹术后可辅助行肝动脉栓塞(HAE),本研究中接受HAE者入院至栓塞中位时间为5小时。

研究设计与关键结果

  • 回顾性队列研究,共1675例符合纳入标准,其中75例(4.5%)在HCL后接受HAE,入院至HAE中位时间5小时。
  • 在225例倾向性评分匹配(2:1)患者中,HCL后HAE与24小时死亡率改善显著相关,但与院内死亡率无关。
  • 在无严重创伤性脑损伤(头部简明损伤定级≤3)亚组(n=189)中,辅助HAE与24小时及院内死亡率均显著改善相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究,证据等级为治疗性研究III级。
  • 局限:作者指出仍需前瞻性研究确定术后HAE的指征。

对床旁实践的改变

  • 作者认为,辅助HAE可能改善因肝损伤行HCL患者的生存;术后HAE的指征仍需前瞻性研究确定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Severe liver injuries pose a challenge to trauma surgeons. While the use of hepatic angioembolization (HAE) has been evaluated as a component of the nonoperative management of liver injury, little is known about the efficacy of postoperative HAE in patients who require hemorrhage control laparotomy (HCL) for liver injury. The purpose of this study is to evaluate the impact of HAE following HCL on patient survival.

METHODS: This is a retrospective cohort study using the American College of Surgeons Trauma Quality Improvement Program database from January 2013 to December 2014. In propensity score matched (2:1) patients who underwent HCL-only or HCL + HAE, the impact of adjunctive use of HAE on patient survival was examined with the Cox proportional hazards regression analysis adjusting for transfusion requirement within 4 hours. We also performed a subgroup analysis in patients without severe traumatic brain injury (Abbreviated Injury Scale head ≤3).

RESULTS: A total of 1,675 patients met our inclusion criteria. Of those, 75 (4.5%) patients underwent HAE after HCL (median hours to HAE, 5 hours after admission). In 225 propensity score-matched patients, the use of HAE following HCL was significantly associated with improved 24-hour mortality, but not in-hospital mortality. In the subgroup of patients without severe traumatic brain injury (n = 189), we observed significant survival benefits (24-hour and in-hospital mortality) associated with the adjunctive use of HAE.

CONCLUSION: The results of our study suggest that the adjunctive use of HAE might improve survival of patients who require HCL for liver injury. Further prospective study to determine the indication for postoperative HAE is still warranted.

LEVEL OF EVIDENCE: Therapeutic study, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Matsushima K, Hogen R, Piccinini A, et al. Adjunctive use of hepatic angioembolization following hemorrhage control laparotomy. J Trauma Acute Care Surg. 2020. PMID: 31977997. doi:10.1097/TA.0000000000002591

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。